相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Establishment and Characterization of an Irinotecan-Resistant Human Colon Cancer Cell Line
Zhuo-Xun Wu et al.
FRONTIERS IN ONCOLOGY (2021)
Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine
Adam Paulik et al.
TUMORI JOURNAL (2020)
Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance
Milad Ashrafizadeh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Implications of ABCC4-Mediated cAMP Efflux for CRC Migration
Jakub Kryczka et al.
CANCERS (2020)
Recent Advances in Use of Topoisomerase Inhibitors in Combination Cancer Therapy
Wenjie Wang et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2019)
Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance)
Heinz-Josef Lenz et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Contribution of Epithelial Plasticity to Therapy Resistance
Patricia G. Santamaria et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Irinotecan: 25 years of cancer treatment
Christian Bailly
PHARMACOLOGICAL RESEARCH (2019)
A Human ABC Transporter ABCC4 Gene SNP (rs11568658, 559 G > T, G187W) Reduces ABCC4-Dependent Drug Resistance
Megumi Tsukamoto et al.
CELLS (2019)
Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer
Jason Timothy Henry et al.
CHINESE CLINICAL ONCOLOGY (2019)
Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?
R. G. Morgan et al.
BRITISH JOURNAL OF CANCER (2018)
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Femke M. de Man et al.
CLINICAL PHARMACOKINETICS (2018)
Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans
Ryoichi Fujiwara et al.
DRUG METABOLISM AND PHARMACOKINETICS (2018)
Cell Migration Related to MDR-Another Impediment to Effective Chemotherapy?
Jakub Kryczka et al.
MOLECULES (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer
Precious Takondwa Makondi et al.
PLOS ONE (2017)
Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials
Paul Ritvo et al.
PREVENTIVE MEDICINE (2017)
Epithelial-mesenchymal transition: potential regulator of ABC transporters in tumor progression
Zong-Sheng Jiang et al.
JOURNAL OF CANCER (2017)
Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer
Teresa Di Desidero et al.
CANCER LETTERS (2017)
Pharmacologic resistance in colorectal cancer: a review
William A. Hammond et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Neuromedin U is upregulated by Snail at early stages of EMT in HT29 colon cancer cells
Patrycja Przygodzka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2016)
Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition
Simona Dinicola et al.
LIFE SCIENCES (2016)
Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells
Virgilio Souza e Silva et al.
ONCOTARGETS AND THERAPY (2016)
The role of ABC transporters in ovarian cancer progression and chemoresistance
M. P. Ween et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance
Niels F. Jensen et al.
MOLECULAR ONCOLOGY (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
The Molecular Taxonomy of Colorectal Cancer: What's New?
Ana Sebio et al.
CURRENT COLORECTAL CANCER REPORTS (2015)
Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2014)
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
Amelie Petitprez et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
Anguraj Sadanandam et al.
NATURE MEDICINE (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
The Role of Tumor Stroma in Cancer Progression and Prognosis Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
M. Saxena et al.
CELL DEATH & DISEASE (2011)
ABCC1: a gateway for pharmacological compounds to the ischaemic brain
Ertugrul Kilic et al.
BRAIN (2008)
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan
Maguy Del Rio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cell lung cancer
Leena Gandhi et al.
CANCER (2007)
A human protein atlas for normal and cancer tissues based on antibody proteomics
M Uhlén et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
分享论文
